Menu
GeneBe

6-152122254-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):c.*182G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.205 in 873,974 control chromosomes in the GnomAD database, including 19,245 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4258 hom., cov: 33)
Exomes 𝑓: 0.20 ( 14987 hom. )

Consequence

SYNE1
NM_182961.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.129
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-152122254-C-T is Benign according to our data. Variant chr6-152122254-C-T is described in ClinVar as [Benign]. Clinvar id is 355803.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152122254-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNE1NM_001347702.2 linkuse as main transcriptc.*182G>A 3_prime_UTR_variant 18/18 ENST00000354674.5
SYNE1NM_182961.4 linkuse as main transcriptc.*182G>A 3_prime_UTR_variant 146/146 ENST00000367255.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNE1ENST00000354674.5 linkuse as main transcriptc.*182G>A 3_prime_UTR_variant 18/185 NM_001347702.2
SYNE1ENST00000367255.10 linkuse as main transcriptc.*182G>A 3_prime_UTR_variant 146/1461 NM_182961.4 P1Q8NF91-1

Frequencies

GnomAD3 genomes
AF:
0.232
AC:
35269
AN:
152044
Hom.:
4258
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.299
Gnomad AMI
AF:
0.162
Gnomad AMR
AF:
0.200
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.124
Gnomad SAS
AF:
0.109
Gnomad FIN
AF:
0.292
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.217
GnomAD4 exome
AF:
0.199
AC:
143496
AN:
721814
Hom.:
14987
Cov.:
10
AF XY:
0.194
AC XY:
72182
AN XY:
371612
show subpopulations
Gnomad4 AFR exome
AF:
0.301
Gnomad4 AMR exome
AF:
0.201
Gnomad4 ASJ exome
AF:
0.183
Gnomad4 EAS exome
AF:
0.142
Gnomad4 SAS exome
AF:
0.110
Gnomad4 FIN exome
AF:
0.265
Gnomad4 NFE exome
AF:
0.205
Gnomad4 OTH exome
AF:
0.198
GnomAD4 genome
AF:
0.232
AC:
35288
AN:
152160
Hom.:
4258
Cov.:
33
AF XY:
0.230
AC XY:
17125
AN XY:
74402
show subpopulations
Gnomad4 AFR
AF:
0.298
Gnomad4 AMR
AF:
0.200
Gnomad4 ASJ
AF:
0.184
Gnomad4 EAS
AF:
0.125
Gnomad4 SAS
AF:
0.109
Gnomad4 FIN
AF:
0.292
Gnomad4 NFE
AF:
0.210
Gnomad4 OTH
AF:
0.214
Alfa
AF:
0.200
Hom.:
3147
Bravo
AF:
0.231
Asia WGS
AF:
0.150
AC:
523
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 18, 2018- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
Cadd
Benign
3.2
Dann
Benign
0.53

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12681; hg19: chr6-152443389; API